GSK2967901A, a novel small molecule SIRT1 activator for the topical treatment of psoriasis

被引:0
|
作者
Ellis, J. [1 ]
Seefeld, M. [1 ]
Miller, W. [1 ]
Fox, R. [1 ]
Evans, K. [1 ]
Atkins, C. [1 ]
Dai, H. [1 ]
Jayawickreme, C. [1 ]
Bedard, M. [1 ]
Santos, L. [1 ]
Gupta, A. [1 ]
Grillot, D. [2 ]
Nicodeme, E. [2 ]
Weiss, M. [1 ]
机构
[1] GSK, Collegeville, PA USA
[2] GSK, Les Ulis, France
关键词
D O I
10.1016/j.jid.2017.07.065
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
LB985
引用
收藏
页码:B10 / B10
页数:1
相关论文
共 50 条
  • [31] Axonal protection by a small molecule SIRT1 activator, SRT2104, with alteration of autophagy in TNF-induced optic nerve degeneration
    Kitaoka, Yasushi
    Sase, Kana
    Tsukahara, Chihiro
    Fujita, Naoki
    Tokuda, Naoto
    Kogo, Jiro
    Takagi, Hitoshi
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2020, 64 (03) : 298 - 303
  • [32] Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
    Shinji Kume
    Munehiro Kitada
    Keizo Kanasaki
    Hiroshi Maegawa
    Daisuke Koya
    Archives of Pharmacal Research, 2013, 36 : 230 - 236
  • [33] 12 weeks of treatment with an oral SIRT1 activator, SRT2104, leads to clinical improvement and skin microarray modification in patients with psoriasis
    Jacobson, E. W.
    Suarez-Farinas, M.
    Cueto, I.
    Katcherian, A.
    Matheson, R.
    Parish, L. C.
    Shortino, D.
    Gupta, A.
    Vlasuk, G. P.
    Krueger, J. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S159 - S159
  • [34] Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
    Kume, Shinji
    Kitada, Munehiro
    Kanasaki, Keizo
    Maegawa, Hiroshi
    Koya, Daisuke
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (02) : 230 - 236
  • [35] Penilumamide, a novel SIRT1 activator, protects UVB-induced photodamages in HaCaT cells
    Park, Ji Won
    Park, Jae Hyeon
    Lee, Haeun
    Wang, Cong
    Cao, Shugeng
    Kim, Hyung Sik
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2025, 88 (03): : 106 - 121
  • [36] Search for a novel SIRT1 activator: Structural modification of SRT1720 and biological evaluation
    Matsuya, Yuji
    Kobayashi, Yuta
    Uchida, Sayumi
    Itoh, Yukihiro
    Sawada, Hideyuki
    Suzuki, Takayoshi
    Miyata, Naoki
    Sugimoto, Kenji
    Toyooka, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4907 - 4910
  • [37] Novel small molecule inhibitors of GSK3β for the treatment of bipolar disorder
    Mohanty, Sarina
    Roberts, Amanda
    Levy, Daniel
    Haggarty, Stephen
    Lapuerta, Pablo
    BIPOLAR DISORDERS, 2024, 26 : 62 - 63
  • [38] Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells
    Tomohiro Kozako
    Takayoshi Suzuki
    Makoto Yoshimitsu
    Yuichiro Uchida
    Ayako Kuroki
    Akiyoshi Aikawa
    Shin-ichiro Honda
    Naomichi Arima
    Shinji Soeda
    Scientific Reports, 5
  • [39] Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells
    Kozako, Tomohiro
    Suzuki, Takayoshi
    Yoshimitsu, Makoto
    Uchida, Yuichiro
    Kuroki, Ayako
    Aikawa, Akiyoshi
    Honda, Shin-ichiro
    Arima, Naomichi
    Soeda, Shinji
    SCIENTIFIC REPORTS, 2015, 5
  • [40] Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo
    Smith, Jesse J.
    Kenney, Renee Deehan
    Gagne, David J.
    Frushour, Brian P.
    Ladd, William
    Galonek, Heidi L.
    Israelian, Kristine
    Song, Jeffrey
    Razvadauskaite, Giedre
    Lynch, Amy V.
    Carney, David P.
    Johnson, Robin J.
    Lavu, Siva
    Iffland, Andre
    Elliott, Peter J.
    Lambert, Philip D.
    Elliston, Keith O.
    Jirousek, Michael R.
    Milne, Jill C.
    Boss, Olivier
    BMC SYSTEMS BIOLOGY, 2009, 3